Impact of rotavirus vaccination on rotavirus and all-cause gastroenteritis in peri-urban Kenyan children
Clicks: 258
ID: 113750
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.0
/100
20 views
20 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A monovalent rotavirus vaccine (RV1) was introduced into the National Immunization Program in Kenya in July 2014. We examined the impact of the vaccine on hospitalization for all-cause acute gastroenteritis (AGE) and rotavirus-specific AGE and strain distribution at a large referral hospital which s …
| Reference Key |
ea2017vaccineimpact
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Wandera EA;Mohammad S;Bundi M;Komoto S;Nyangao J;Kathiiko C;Odoyo E;Miring'u G;Taniguchi K;Ichinose Y;; |
| Journal | Vaccine |
| Year | 2017 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
Genotype
hospitalization
gastroenteritis / prevention & control*
rotavirus / immunology
kenya
immunization programs
pmid:28780116
doi:10.1016/j.vaccine.2017.07.096
ernest apondi wandera
shah mohammad
yoshio ichinose
gastroenteritis / immunology
rotavirus / pathogenicity*
rotavirus vaccines / therapeutic use*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.